ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

84.50

+1.22 (1.46%)

At close: Jun 26, 2026, 4:00 PM EDT

85.00

+0.50 (0.59%)

After-hours: Jun 26, 2026, 7:18 PM EDT

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,792	1,775	1,167	1,129	704	776
Market Cap Growth	31.57%	52.16%	3.40%	60.35%	-9.25%	116.16%
Enterprise Value	2,096	2,098	1,665	1,218	966.94	987.41
Last Close Price	84.50	78.94	55.28	55.14	40.23	46.08
PE Ratio	21.65	23.78	-	64.87	-	-
Forward PE	9.16	10.03	10.72	14.04	14.79	12.86
PEG Ratio	-	1.38	1.38	1.38	1.11	1.02
PS Ratio	1.94	2.01	1.90	2.32	2.22	3.59
PB Ratio	3.21	3.28	2.89	2.61	2.24	2.32
P/TBV Ratio	54.14	-	-	5.13	19.33	48.60
P/FCF Ratio	9.37	-	24.42	10.25	-	1013.74
P/OCF Ratio	8.59	-	18.23	9.49	-	233.45
EV/Sales Ratio	2.27	2.37	2.71	2.50	3.06	4.57
EV/EBITDA Ratio	10.62	18.88	24.37	11.41	39.68	132.38
EV/EBIT Ratio	19.42	18.88	2850.40	25.93	-	-
EV/FCF Ratio	10.96	-	34.84	11.06	-	1290.74
Debt / Equity Ratio	1.09	1.14	1.46	0.62	0.85	0.80
Debt / EBITDA Ratio	4.96	5.55	9.14	2.68	11.76	38.52
Debt / FCF Ratio	-	-	13.06	2.60	-	375.62
Net Debt / Equity Ratio	0.51	0.60	1.17	0.15	0.76	0.56
Net Debt / EBITDA Ratio	2.32	2.90	6.92	0.61	9.78	25.08
Net Debt / FCF Ratio	-	-	9.90	0.59	-5.95	244.51
Asset Turnover	0.65	0.65	0.56	0.58	0.41	0.35
Inventory Turnover	2.53	2.44	2.02	1.68	1.48	1.41
Quick Ratio	2.43	2.07	1.93	2.63	2.15	2.61
Current Ratio	3.12	2.71	2.72	3.57	3.46	3.68
Return on Equity (ROE)	16.71%	16.16%	-4.18%	4.72%	-13.74%	-15.37%
Return on Assets (ROA)	6.87%	6.67%	0.04%	5.33%	-3.52%	-4.91%
Return on Invested Capital (ROIC)	10.57%	9.41%	0.06%	7.19%	-4.26%	-5.82%
Return on Capital Employed (ROCE)	10.56%	9.86%	0.06%	6.62%	-5.25%	-7.46%
Earnings Yield	4.68%	4.21%	-	1.54%	-	-
FCF Yield	10.67%	0.00%	4.09%	9.76%	-	0.10%
Buyback Yield / Dilution	-11.10%	-9.89%	-6.18%	-11.89%	-29.77%	-4.73%
Total Shareholder Return	-11.10%	-9.89%	-6.18%	-11.89%	-29.77%	-4.73%

SEC Filings: 10-K · 10-Q